News
Insilico Medicine said the orally available drug, ISM8969, was developed using its proprietary Pharma.AI platform. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback